As of February 13 at 1:23:05 PM EST. Market Open.

Bashar Masri, a Palestinian-American billionaire, has quietly positioned himself as a key player in the Trump administration’s post-war plans for Gaza. According to diplomatic sources ...

an increase of approximately $5 million from December 31, 2023. Revenue Guidance (2025): $610 million to $630 million, representing 0% to 3% growth over 2024. 10x Genomics Inc (NASDAQ:TXG ...

Serge Saxonov, the Chief Executive Officer of $TXG, sold 7,942 shares of the company on 02-28-2025 for an estimated $84,393. We received data on the trade from a ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.

10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports.

10x Genomics (NASDAQ:TXG – Free Report ... CWM LLC grew its holdings in shares of 10x Genomics by 444.5% during the 3rd quarter. CWM LLC now owns 22,810 shares of the company’s stock worth ...

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa ...

Citi lowered the firm’s price target on 10x Genomics (TXG) to $15 from $20 and keeps a Buy rating on the shares. The firm updated models in the life science tools and diagnostics group post the ...

CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...

Clashes between government security forces and supporters of ousted former President Bashar al-Assad have killed at least 311 people in Syria since Thursday, according to a monitoring group that ...